<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>peptides typeshit</title><link>https://typeshit.news/peptides/</link><description></description><item><title>The Times hears from women who got pregnant while taking Mounjaro</title><link>https://typeshit.news/peptides/the-times-hears-from-women-who-got-pregnant-while-taking-mounjaro</link><guid isPermaLink="true">https://typeshit.news/peptides/the-times-hears-from-women-who-got-pregnant-while-taking-mounjaro</guid><pubDate>Sun, 18 Oct 2026 19:00:00 +0000</pubDate><description>One writer shares her own unexpected pregnancy while taking the tirzepatide shot, and says many others have been through the same thing.</description></item><item><title>Experimental injection that makes fat cells self destruct shows early promise</title><link>https://typeshit.news/peptides/experimental-injection-that-makes-fat-cells-self-destruct-shows-early</link><guid isPermaLink="true">https://typeshit.news/peptides/experimental-injection-that-makes-fat-cells-self-destruct-shows-early</guid><pubDate>Sun, 18 Oct 2026 17:30:04 +0000</pubDate><description>Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.</description></item><item><title>Philstar Life on semaglutide and the PIONEER 8 trial</title><link>https://typeshit.news/peptides/philstar-life-on-semaglutide-and-the-pioneer-8-trial</link><guid isPermaLink="true">https://typeshit.news/peptides/philstar-life-on-semaglutide-and-the-pioneer-8-trial</guid><pubDate>Sun, 18 Oct 2026 17:01:47 +0000</pubDate><description>A short Philstar Life item on PIONEER 8, a trial of oral semaglutide. The material gives only the title, so tap through for the details.</description></item><item><title>Mochi Health cuts prices on compounded semaglutide and tirzepatide</title><link>https://typeshit.news/peptides/mochi-health-cuts-prices-on-compounded-semaglutide-and-tirzepatide</link><guid isPermaLink="true">https://typeshit.news/peptides/mochi-health-cuts-prices-on-compounded-semaglutide-and-tirzepatide</guid><pubDate>Sun, 18 Oct 2026 16:30:17 +0000</pubDate><description>The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.</description></item><item><title>Andrew Huberman on certified USA made peptides and verified standards</title><link>https://typeshit.news/peptides/the-whole-peptide-game-changes-when-they-are-certified-usa-made-and-are</link><guid isPermaLink="true">https://typeshit.news/peptides/the-whole-peptide-game-changes-when-they-are-certified-usa-made-and-are</guid><pubDate>Sun, 18 Oct 2026 16:20:51 +0000</pubDate><description>Huberman says verified, US-made sourcing would change the peptide market, and wonders which compounds beyond GLPs would qualify.</description></item><item><title>IOHA explains why burning stored body fat is harder than it seems</title><link>https://typeshit.news/peptides/ioha-explains-why-burning-stored-body-fat-is-harder-than-it-seems</link><guid isPermaLink="true">https://typeshit.news/peptides/ioha-explains-why-burning-stored-body-fat-is-harder-than-it-seems</guid><pubDate>Sun, 18 Oct 2026 16:13:15 +0000</pubDate><description>A general explainer on why the body holds onto its large fat reserves even though they carry tens of thousands of calories.</description></item><item><title>Dr Aryanna Amini cautions against comparing two separate retatrutide studies</title><link>https://typeshit.news/peptides/dr-aryanna-amini-cautions-against-comparing-two-separate-retatrutide</link><guid isPermaLink="true">https://typeshit.news/peptides/dr-aryanna-amini-cautions-against-comparing-two-separate-retatrutide</guid><pubDate>Sun, 18 Oct 2026 16:06:22 +0000</pubDate><description>She points out one trial enrolled people with diabetes and the other excluded them, so the results aren't a head to head match.</description></item><item><title>Medik8 pairs Liquid Peptides Advanced MP with Crystal Retinal for nights</title><link>https://typeshit.news/peptides/if-your-skin-is-craving-bounce-smoothness-and-that-lit-from-within</link><guid isPermaLink="true">https://typeshit.news/peptides/if-your-skin-is-craving-bounce-smoothness-and-that-lit-from-within</guid><pubDate>Sun, 18 Oct 2026 16:00:24 +0000</pubDate><description>The skincare brand suggests applying its peptide serum first for hydration, then retinal at night for anti-ageing.</description></item><item><title>International Myeloma Foundation looks at GLP-1 drug safety for myeloma patients</title><link>https://typeshit.news/peptides/are-glp-1-weight-loss-medications-safe-for-myeloma-patients-especially</link><guid isPermaLink="true">https://typeshit.news/peptides/are-glp-1-weight-loss-medications-safe-for-myeloma-patients-especially</guid><pubDate>Sun, 18 Oct 2026 15:46:35 +0000</pubDate><description>The IMF addresses whether GLP-1 weight loss medications are a safe option for people with myeloma, including those with insulin resistance.</description></item><item><title>Roseland Lashay shares her maintenance meals after losing 60 lbs on tirzepatide</title><link>https://typeshit.news/peptides/roseland-lashay-shares-her-maintenance-meals-after-losing-60-lbs-on</link><guid isPermaLink="true">https://typeshit.news/peptides/roseland-lashay-shares-her-maintenance-meals-after-losing-60-lbs-on</guid><pubDate>Sun, 18 Oct 2026 15:43:26 +0000</pubDate><description>A full day of low carb, high protein eating from Roseland Lashay as she shifts into maintenance on tirzepatide.</description></item><item><title>Samuel Hume lists three big psoriasis drug advances, including tirzepatide</title><link>https://typeshit.news/peptides/samuel-hume-lists-three-big-psoriasis-drug-advances-including</link><guid isPermaLink="true">https://typeshit.news/peptides/samuel-hume-lists-three-big-psoriasis-drug-advances-including</guid><pubDate>Sun, 18 Oct 2026 15:27:00 +0000</pubDate><description>Icotrokinra became the first approved oral IL23 receptor blocker, and a trial found tirzepatide plus ixekizumab gave deeper responses.</description></item><item><title>Oral Wegovy scripts dip 3.3% while Zepbound keeps a wide lead over Novo</title><link>https://typeshit.news/peptides/oral-wegovy-scripts-dip-3-3-while-zepbound-keeps-a-wide-lead-over-novo</link><guid isPermaLink="true">https://typeshit.news/peptides/oral-wegovy-scripts-dip-3-3-while-zepbound-keeps-a-wide-lead-over-novo</guid><pubDate>Sun, 18 Oct 2026 15:15:00 +0000</pubDate><description>Oral Wegovy fell to about 173,500 weekly prescriptions and Foundayo rose to 60,151. Novo also eyes 15 to 20% yearly GLP-1 growth in India.</description></item><item><title>Dr Almerie looks at what retatrutide may do beyond weight loss</title><link>https://typeshit.news/peptides/retatrutide-is-weight-loss-just-the-tip-of-the-iceberg</link><guid isPermaLink="true">https://typeshit.news/peptides/retatrutide-is-weight-loss-just-the-tip-of-the-iceberg</guid><pubDate>Sun, 18 Oct 2026 15:01:08 +0000</pubDate><description>Physician Dr Almerie talks through retatrutide and the effects it may have past the number on the scale.</description></item><item><title>Fitwithliz shares a day of eating on Wegovy after dropping 50 lbs</title><link>https://typeshit.news/peptides/what-i-eat-on-wegovy-50lb-down-cooking-skincare-catch-up</link><guid isPermaLink="true">https://typeshit.news/peptides/what-i-eat-on-wegovy-50lb-down-cooking-skincare-catch-up</guid><pubDate>Sun, 18 Oct 2026 14:00:49 +0000</pubDate><description>Liz cooks her meals for the day, runs through her skincare and catches viewers up on life 50 lbs into Wegovy.</description></item><item><title>USA TODAY says much of the podcast talk about experimental peptides is misleading</title><link>https://typeshit.news/peptides/experimental-peptides-are-all-the-rage-in-longevity-and-optimization</link><guid isPermaLink="true">https://typeshit.news/peptides/experimental-peptides-are-all-the-rage-in-longevity-and-optimization</guid><pubDate>Sun, 18 Oct 2026 14:00:24 +0000</pubDate><description>Peptides have become a favorite of longevity and optimization podcasts, and USA TODAY looks at where those claims go wrong.</description></item><item><title>HighFold-Lasso extends AlphaFold3 to predict lasso peptide structures</title><link>https://typeshit.news/peptides/highfold-lasso-extends-alphafold3-to-predict-lasso-peptide-structures</link><guid isPermaLink="true">https://typeshit.news/peptides/highfold-lasso-extends-alphafold3-to-predict-lasso-peptide-structures</guid><pubDate>Sun, 18 Oct 2026 13:53:17 +0000</pubDate><description>Researchers built a topology-guided add-on to AlphaFold3 aimed at the threaded tail that trips up lasso peptide structure prediction.</description></item><item><title>Mushroom peptide ASHGEGF boosts how salty food tastes by about 70%</title><link>https://typeshit.news/peptides/mushroom-peptide-ashgegf-boosts-how-salty-food-tastes-by-about-70</link><guid isPermaLink="true">https://typeshit.news/peptides/mushroom-peptide-ashgegf-boosts-how-salty-food-tastes-by-about-70</guid><pubDate>Sun, 18 Oct 2026 13:03:00 +0000</pubDate><description>Gannan Medical University researchers screened 6,000 candidates from Hypsizygus marmoreus and found peptides that may help cut sodium without losing flavor.</description></item><item><title>Dr Bazgha Khalid explains retatrutide, the weight loss drug still in trials</title><link>https://typeshit.news/peptides/dr-bazgha-khalid-explains-retatrutide-the-weight-loss-drug-still-in</link><guid isPermaLink="true">https://typeshit.news/peptides/dr-bazgha-khalid-explains-retatrutide-the-weight-loss-drug-still-in</guid><pubDate>Sun, 18 Oct 2026 13:00:08 +0000</pubDate><description>A weight loss doctor walks through retatrutide, which she calls the most anticipated obesity drug currently in clinical trials.</description></item><item><title>Allegheny County starts $13.3M trial of Ozempic for opioid and alcohol addiction</title><link>https://typeshit.news/peptides/allegheny-county-starts-13-3m-trial-of-ozempic-for-opioid-and-alcohol</link><guid isPermaLink="true">https://typeshit.news/peptides/allegheny-county-starts-13-3m-trial-of-ozempic-for-opioid-and-alcohol</guid><pubDate>Sun, 18 Oct 2026 12:30:17 +0000</pubDate><description>The Pennsylvania county is funding a study into whether the GLP-1 drug can help people with substance use disorders.</description></item><item><title>KFF Health News looks at misleading peptide claims on longevity podcasts</title><link>https://typeshit.news/peptides/experimental-peptides-are-all-the-rage-in-longevity-and-optimization-2</link><guid isPermaLink="true">https://typeshit.news/peptides/experimental-peptides-are-all-the-rage-in-longevity-and-optimization-2</guid><pubDate>Sun, 18 Oct 2026 12:30:15 +0000</pubDate><description>Amy Maxmen reports on how experimental peptides are being hyped in optimization circles and where the talk goes wrong.</description></item><item><title>A man on what Ozempic did for his compulsive eating, and what came after</title><link>https://typeshit.news/peptides/a-man-on-what-ozempic-did-for-his-compulsive-eating-and-what-came-after</link><guid isPermaLink="true">https://typeshit.news/peptides/a-man-on-what-ozempic-did-for-his-compulsive-eating-and-what-came-after</guid><pubDate>Sun, 18 Oct 2026 12:30:14 +0000</pubDate><description>A personal story about the control he felt on the drug and the cravings for it that followed once he stopped.</description></item><item><title>EU medicines committee recommends Lilly's Foundayo pill for obesity and diabetes</title><link>https://typeshit.news/peptides/eu-medicines-committee-recommends-lillys-foundayo-pill-for-obesity-and</link><guid isPermaLink="true">https://typeshit.news/peptides/eu-medicines-committee-recommends-lillys-foundayo-pill-for-obesity-and</guid><pubDate>Sun, 18 Oct 2026 12:04:47 +0000</pubDate><description>The CHMP opinion from 15 October now goes to the European Commission. In trials, people on the daily orforglipron tablet lost about 5% to 11% of body weight over 72 weeks.</description></item><item><title>Patent histories of 25 gray-market peptides show deep ties to big pharma</title><link>https://typeshit.news/peptides/the-almost-unbelievable-relationship-between-big-pharma-and-gray-market</link><guid isPermaLink="true">https://typeshit.news/peptides/the-almost-unbelievable-relationship-between-big-pharma-and-gray-market</guid><pubDate>Sun, 18 Oct 2026 11:21:56 +0000</pubDate><description>Dr David Barzilai traced the development records of popular compounds and found many trace back to pharmaceutical companies.</description></item><item><title>Bahrain's NHRA approves Wegovy pills for treating obesity</title><link>https://typeshit.news/peptides/bahrains-nhra-approves-wegovy-pills-for-treating-obesity</link><guid isPermaLink="true">https://typeshit.news/peptides/bahrains-nhra-approves-wegovy-pills-for-treating-obesity</guid><pubDate>Sun, 18 Oct 2026 11:03:35 +0000</pubDate><description>The country's health regulator has cleared the oral version of Novo Nordisk's semaglutide for weight management.</description></item><item><title>Mochi Health moves to dose-based GLP-1 pricing and launches Mochi Labs bloodwork</title><link>https://typeshit.news/peptides/mochi-health-moves-to-dose-based-glp-1-pricing-and-launches-mochi-labs</link><guid isPermaLink="true">https://typeshit.news/peptides/mochi-health-moves-to-dose-based-glp-1-pricing-and-launches-mochi-labs</guid><pubDate>Sun, 18 Oct 2026 11:03:00 +0000</pubDate><description>Compounded semaglutide and tirzepatide now cost less at lower starting doses, and members can order cholesterol, A1C and thyroid panels in the same app.</description></item><item><title>Mochi Health cuts compounded semaglutide and tirzepatide prices, adds lab testing</title><link>https://typeshit.news/peptides/mochi-health-cuts-compounded-semaglutide-and-tirzepatide-prices-adds</link><guid isPermaLink="true">https://typeshit.news/peptides/mochi-health-cuts-compounded-semaglutide-and-tirzepatide-prices-adds</guid><pubDate>Sun, 18 Oct 2026 11:03:00 +0000</pubDate><description>Pricing now scales with dose, so people on lower starting doses pay less. The new Mochi Labs bloodwork service tracks A1C, cholesterol and thyroid, though not in NY, NJ, RI or HI.</description></item><item><title>Investor breaks down Hims &amp; Hers stock after a 56% drop and its GLP-1 pivot</title><link>https://typeshit.news/peptides/investor-breaks-down-hims-and-hers-stock-after-a-56-drop-and-its-glp-1</link><guid isPermaLink="true">https://typeshit.news/peptides/investor-breaks-down-hims-and-hers-stock-after-a-56-drop-and-its-glp-1</guid><pubDate>Sun, 18 Oct 2026 10:58:38 +0000</pubDate><description>Inversor Bético rates the business strongly but says entry timing isn't there yet, pointing to margins squeezed by the move from compounded to branded GLP-1s.</description></item><item><title>Bahrain's NHRA approves Wegovy pills, oral semaglutide for obesity</title><link>https://typeshit.news/peptides/bahrains-nhra-approves-wegovy-pills-oral-semaglutide-for-obesity</link><guid isPermaLink="true">https://typeshit.news/peptides/bahrains-nhra-approves-wegovy-pills-oral-semaglutide-for-obesity</guid><pubDate>Sun, 18 Oct 2026 10:17:30 +0000</pubDate><description>Bahrain's National Health Regulatory Authority signed off on the oral GLP-1 version of Wegovy for treating obesity, per the state news agency.</description></item><item><title>Eli Lilly posts $22.97B quarter and plans a retatrutide FDA filing in early 2027</title><link>https://typeshit.news/peptides/eli-lilly-posts-22-97b-quarter-and-plans-a-retatrutide-fda-filing-in</link><guid isPermaLink="true">https://typeshit.news/peptides/eli-lilly-posts-22-97b-quarter-and-plans-a-retatrutide-fda-filing-in</guid><pubDate>Sun, 18 Oct 2026 10:14:19 +0000</pubDate><description>Revenue rose 48% on Mounjaro and Zepbound demand, and Lilly raised 2026 guidance to $85B to $87B. CEO David Ricks calls retatrutide the next growth driver.</description></item><item><title>Peptide compounders face growing USP 795 and 797 scrutiny from regulators</title><link>https://typeshit.news/peptides/as-peptides-go-mainstream-usp-and-matter-more-than-ever</link><guid isPermaLink="true">https://typeshit.news/peptides/as-peptides-go-mainstream-usp-and-matter-more-than-ever</guid><pubDate>Sun, 18 Oct 2026 09:52:49 +0000</pubDate><description>A pharmacy attorney explains why boards and plaintiffs now treat USP standards as the baseline, and why research use only labels won't shield sloppy compounding.</description></item><item><title>Dr Sheth pairs copper peptides with retinol for firmer skin and a stronger barrier</title><link>https://typeshit.news/peptides/retinol-renews-copper-peptides-help-rebuild-skin-resilience-while</link><guid isPermaLink="true">https://typeshit.news/peptides/retinol-renews-copper-peptides-help-rebuild-skin-resilience-while</guid><pubDate>Sun, 18 Oct 2026 09:24:02 +0000</pubDate><description>Retinol speeds up cell turnover while copper peptides back skin repair and collagen and elastin production. A short skincare explainer on using both.</description></item><item><title>Polskie Radio warns weight-loss drugs like Ozempic are driving a quiet health crisis</title><link>https://typeshit.news/peptides/weight-loss-drugs-like-ozempic-are-sparking-a-quiet-health-crisis</link><guid isPermaLink="true">https://typeshit.news/peptides/weight-loss-drugs-like-ozempic-are-sparking-a-quiet-health-crisis</guid><pubDate>Sun, 18 Oct 2026 09:23:24 +0000</pubDate><description>A Polish Radio piece argues that Ozempic and similar weight-loss drugs are creating health problems that get little attention.</description></item><item><title>University of Missouri doctor warns against buying gray-market peptides like BPC-157</title><link>https://typeshit.news/peptides/university-of-missouri-doctor-warns-about-buying-peptides-on-the-gray</link><guid isPermaLink="true">https://typeshit.news/peptides/university-of-missouri-doctor-warns-about-buying-peptides-on-the-gray</guid><pubDate>Sun, 18 Oct 2026 09:00:00 +0000</pubDate><description>Dr. Regina DePietro of MU Health Care says unapproved injectables sold "for research" lack safety checks, and the products could be fake or useless.</description></item><item><title>Nutritionist Kim Pearson on keeping weight off after stopping GLP-1 drugs</title><link>https://typeshit.news/peptides/why-weight-regain-is-so-common-after-glp-1-medicationsand-what-actually</link><guid isPermaLink="true">https://typeshit.news/peptides/why-weight-regain-is-so-common-after-glp-1-medicationsand-what-actually</guid><pubDate>Sun, 18 Oct 2026 09:00:00 +0000</pubDate><description>One semaglutide trial saw about two thirds of lost weight return within a year. Pearson points to protein, strength training, sleep and weekly weigh-ins.</description></item><item><title>Novo Nordisk cuts the price of its weight loss drug Wegovy in China</title><link>https://typeshit.news/peptides/novo-nordisk-cuts-the-price-of-its-weight-loss-drug-wegovy-in-china</link><guid isPermaLink="true">https://typeshit.news/peptides/novo-nordisk-cuts-the-price-of-its-weight-loss-drug-wegovy-in-china</guid><pubDate>Sun, 18 Oct 2026 08:25:14 +0000</pubDate><description>Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.</description></item><item><title>Polskie Radio looks at Mounjaro's FDA approval status for weight loss</title><link>https://typeshit.news/peptides/polskie-radio-looks-at-mounjaros-fda-approval-status-for-weight-loss</link><guid isPermaLink="true">https://typeshit.news/peptides/polskie-radio-looks-at-mounjaros-fda-approval-status-for-weight-loss</guid><pubDate>Sun, 18 Oct 2026 08:10:44 +0000</pubDate><description>A brief Polskie Radio item on whether Mounjaro is FDA approved for weight loss. Little detail is available beyond the topic itself.</description></item><item><title>xitsnemox hits week 13 on Wegovy tablets and starts the 25mg dose</title><link>https://typeshit.news/peptides/week-13-on-wegovy-glp-1-tablets-uk-first-week-on-the-25mg-dose</link><guid isPermaLink="true">https://typeshit.news/peptides/week-13-on-wegovy-glp-1-tablets-uk-first-week-on-the-25mg-dose</guid><pubDate>Sun, 18 Oct 2026 08:00:49 +0000</pubDate><description>A UK vlogger taking oral semaglutide checks in on the first week at the higher 25mg dose of the Wegovy pill.</description></item><item><title>Novo Nordisk's experimental drug amycretin shows significant weight loss</title><link>https://typeshit.news/peptides/novo-nordisks-experimental-drug-amycretin-shows-significant-weight-loss</link><guid isPermaLink="true">https://typeshit.news/peptides/novo-nordisks-experimental-drug-amycretin-shows-significant-weight-loss</guid><pubDate>Sun, 18 Oct 2026 07:42:16 +0000</pubDate><description>Meteo.gr reports strong weight loss results for amycretin, Novo Nordisk's next obesity candidate. Few details were given beyond the headline.</description></item><item><title>About 5,500 of Kalundborg's 16,500 residents work for Novo Nordisk</title><link>https://typeshit.news/peptides/did-you-know-in-kalundborg-a-danish-town-of-about-16-500-people-around</link><guid isPermaLink="true">https://typeshit.news/peptides/did-you-know-in-kalundborg-a-danish-town-of-about-16-500-people-around</guid><pubDate>Sun, 18 Oct 2026 07:28:08 +0000</pubDate><description>The Danish town that makes Ozempic and Wegovy is nicknamed Novo Town, a sign of how much these drugs have reshaped one place.</description></item><item><title>Dermatologist Dr. Madz Abraham explains collagen peptide science on NET 25</title><link>https://typeshit.news/peptides/dermatologist-dr-madz-abraham-explains-collagen-peptide-science-on-net</link><guid isPermaLink="true">https://typeshit.news/peptides/dermatologist-dr-madz-abraham-explains-collagen-peptide-science-on-net</guid><pubDate>Sun, 18 Oct 2026 07:27:26 +0000</pubDate><description>Dr. Madz Abraham went on NET 25 with host Kada Umaga to talk through the science behind collagen peptides. A skincare angle on the peptide conversation.</description></item><item><title>Dr Clay Moss asks whether GLP-1 alone is already being outpaced by newer drugs</title><link>https://typeshit.news/peptides/the-glp-1-receptor-really-kicked-off-the-weight-loss-drug-era-but-is-it</link><guid isPermaLink="true">https://typeshit.news/peptides/the-glp-1-receptor-really-kicked-off-the-weight-loss-drug-era-but-is-it</guid><pubDate>Sun, 18 Oct 2026 06:15:11 +0000</pubDate><description>He sets semaglutide's 14.9% average weight loss in its main obesity trial against tirzepatide's 20.9% at the top dose.</description></item><item><title>Polskie Radio looks at how well the Wegovy pill works for weight loss</title><link>https://typeshit.news/peptides/polskie-radio-looks-at-how-well-the-wegovy-pill-works-for-weight-loss</link><guid isPermaLink="true">https://typeshit.news/peptides/polskie-radio-looks-at-how-well-the-wegovy-pill-works-for-weight-loss</guid><pubDate>Sun, 18 Oct 2026 04:54:20 +0000</pubDate><description>An explainer on the effectiveness of oral Wegovy, the daily semaglutide pill. Little detail is available beyond the headline.</description></item><item><title>Eli Lilly lowers the price of its weight loss drug, per a brief report</title><link>https://typeshit.news/peptides/eli-lilly-lowers-the-price-of-its-weight-loss-drug</link><guid isPermaLink="true">https://typeshit.news/peptides/eli-lilly-lowers-the-price-of-its-weight-loss-drug</guid><pubDate>Sun, 18 Oct 2026 04:43:19 +0000</pubDate><description>A thin search result says Lilly has cut the price of its weight loss drug. No figures, dates or product names are included.</description></item><item><title>Rutgers study ties GLP-1 drugs to 3 to 4 extra sudden vision loss cases per 10,000</title><link>https://typeshit.news/peptides/rutgers-study-ties-glp-1-drugs-to-3-to-4-extra-sudden-vision-loss-cases</link><guid isPermaLink="true">https://typeshit.news/peptides/rutgers-study-ties-glp-1-drugs-to-3-to-4-extra-sudden-vision-loss-cases</guid><pubDate>Sun, 18 Oct 2026 03:15:00 +0000</pubDate><description>Researchers looked at U.S. adults with type 2 diabetes starting a GLP-1 and estimate a small added risk of sudden vision loss that is often permanent.</description></item><item><title>Dr. Rakesh Bansal on GLP-1 drugs shrinking plus sizes in the West</title><link>https://typeshit.news/peptides/weight-loss-drugs-shrink-plus-sizes-in-west-india-watching-closely-glp</link><guid isPermaLink="true">https://typeshit.news/peptides/weight-loss-drugs-shrink-plus-sizes-in-west-india-watching-closely-glp</guid><pubDate>Sun, 18 Oct 2026 03:12:51 +0000</pubDate><description>Bansal notes about 21% of US households now have a GLP-1 user, up from 9% in early 2025, and says India is watching the shift in fashion closely.</description></item><item><title>Amazon Pharmacy starts offering the new oral Wegovy weight loss pill</title><link>https://typeshit.news/peptides/amazon-pharmacy-starts-offering-the-new-oral-wegovy-weight-loss-pill</link><guid isPermaLink="true">https://typeshit.news/peptides/amazon-pharmacy-starts-offering-the-new-oral-wegovy-weight-loss-pill</guid><pubDate>Sun, 18 Oct 2026 03:10:02 +0000</pubDate><description>Novo Nordisk's pill form of Wegovy is now available to order through Amazon Pharmacy, per Polskie Radio. Details on pricing weren't included.</description></item><item><title>University of Missouri doctor warns against gray-market peptides like BPC-157</title><link>https://typeshit.news/peptides/university-of-missouri-doctor-warns-about-buying-peptides-on-the-gray-2</link><guid isPermaLink="true">https://typeshit.news/peptides/university-of-missouri-doctor-warns-about-buying-peptides-on-the-gray-2</guid><pubDate>Sun, 18 Oct 2026 02:00:00 +0000</pubDate><description>Dr. Regina DePietro of MU Health Care says unapproved peptides sold for research lack the safety checks Ozempic went through, and suggests asking a doctor first.</description></item><item><title>Brain peptides pitched as injectable boosts for focus and productivity</title><link>https://typeshit.news/peptides/would-you-inject-an-unregulated-substance-that-promises-to-make-you</link><guid isPermaLink="true">https://typeshit.news/peptides/would-you-inject-an-unregulated-substance-that-promises-to-make-you</guid><pubDate>Sun, 18 Oct 2026 01:00:15 +0000</pubDate><description>A Facebook teaser on unregulated brain peptides sold with promises of sharper thinking and more output. Little detail beyond the hook.</description></item><item><title>Many compounded GLP-1 users say they take brand-name drugs, study finds</title><link>https://typeshit.news/peptides/many-compounded-glp-1-users-say-they-take-brand-name-drugs-study-finds</link><guid isPermaLink="true">https://typeshit.news/peptides/many-compounded-glp-1-users-say-they-take-brand-name-drugs-study-finds</guid><pubDate>Sun, 18 Oct 2026 01:00:05 +0000</pubDate><description>Photos online users uploaded mostly matched what they reported, but over 65% on compounded semaglutide or tirzepatide called it the brand version, Medscape reports.</description></item><item><title>Novo Nordisk will start selling its weight-loss drug Wegovy in vials</title><link>https://typeshit.news/peptides/novo-nordisk-will-sell-its-weight-loss-drug-wegovy-in-vials</link><guid isPermaLink="true">https://typeshit.news/peptides/novo-nordisk-will-sell-its-weight-loss-drug-wegovy-in-vials</guid><pubDate>Sat, 17 Oct 2026 23:41:36 +0000</pubDate><description>Novo Nordisk plans to offer Wegovy in vials as well as its usual format. The report gives no timing or pricing yet.</description></item></channel></rss>